LEDERMAN SETH (Chief Executive Officer) purchased 80000.0% of their position (4K shares) of TONIX PHARMACEUTICALS HOLDING CORP. on the open market
Open‑market purchase worth $86.2K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 5/15/2025ACC: 0001999371-25-006261
DirectorOfficer· Chief Executive Officer
Since Jun 2018
+4K
Net shares
Net buyer
$86.2K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
4K acquired
Non-Derivative Transactions1
Common Stock, $0.001 par value
Direct
Shares
+4K
Price / share
$21.55
Trade value
$86.20K
% of position
80000.0%
5/15/2025
5.00→4K
Total
Net shares
+4K
Net value
$86.20K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 par value Direct | 5/15/2025 | P · Purchase | +4K | $21.55 | $86.20K | 80000.0% | 5.00 | 4K |
| Total | +4K | $86.20K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock, $0.001 par value
IndirectShares owned1.00
Common Stock, $0.001 par value
IndirectShares owned1.00
Total
2.00 indirect2.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock, $0.001 par value | 1.00 | Indirect |
| Common Stock, $0.001 par value | 1.00 | Indirect |
| Total | 2.00 | 2.00 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported